Landmark Glyphosate Trial Begins in France Over Alleged Congenital Malformations

The Grataloup family seeks to establish a link between glyphosate exposure during pregnancy and their son Théo's severe birth defects in a globally unprecedented case against Bayer-Monsanto.

The trial, which began on April 3, 2025, at the tribunal judiciaire de Vienne, is the first worldwide to address congenital malformations allegedly linked to glyphosate exposure.
Théo Grataloup, now 17, was born with severe malformations of the trachea and esophagus, requiring over 50 surgeries to date.
His mother, Sabine Grataloup, unknowingly used a glyphosate-based herbicide during early pregnancy in 2006, a critical period for fetal development.
The family is seeking judicial recognition of a causal link between glyphosate and Théo's condition, as well as damages from Bayer-Monsanto.
Bayer has not commented on the case, which could set a global precedent for corporate accountability in glyphosate-related health risks.